Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

PI Industries Earnings Call: Key Takeaways

PI Industries reported a challenging Q4FY26 with revenue and PAT down 12% and 39% respectively due to global agrochemical contraction, while maintaining healthy 58% gross margins.

Why this was an Alfa AlertNot a filter event. Financials showed a decline and EBITDA margin of 25% was in line with guidance.
Highlights
Revenue growthFY26: (16)% YoY; Q4FY26: (12)% YoY
MarginsFY26 EBITDA margin at 25%, guided target achieved.
Order bookOrder book remains supportive for FY27.
Demand visibilityStrong order book continues to support FY27 growth outlook.
Management confidenceCautious optimism for H2FY27 based on customer offtake plans.

Growth

FY26 revenue fell 16% to ₹67,137 Mn; EBITDA dropped 22% to ₹17,053 Mn. Pharma grew 40% Y-o-Y.

Outlook

Guided for 5+ new molecule launches in FY27; total FY26 capex stood at ₹11,508 Mn.

Risks

Global agrochemical industry contraction, elevated domestic inventory leading to pricing pressure, and adverse weather conditions impacting demand.

Source

Earnings Call filed with BSE, NSE: PIIND. Summary written with AI assistance from the document.

Read the document ↗

PI Industries Ltd: key numbers

Share price
₹2,400.00
Market cap
₹36,412 Cr
Revenue (annual)
₹6,714 Cr
Net profit (annual)
₹1,321 Cr
P/E (TTM)
31.3×Sector 37.5×
Promoter holding
46.09%+0.00% QoQ
FII holding
14.83%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from PI Industries Ltd

All →
12:17 IST BSE
Other Announcement

PI Industries Other Announcement

Bhavina J Dholariya, an immediate relative of an insider, sold equity shares of PI Industries Ltd. The market sale was valued at ₹0.12 Crore.

Value
₹0.12 Cr
18:39 IST BSE
Product Launch

PI Industries Product Launch

PI Industries received registration for its indigenously developed insecticide, 'Pioxaniliprole' (branded 'Pioxazon'), marking a key milestone in its agricultural innovation journey.